Pfizer (PFE)
(Delayed Data from NYSE)
$29.49 USD
+0.18 (0.61%)
Updated Jun 4, 2024 04:00 PM ET
After-Market: $29.54 +0.05 (0.17%) 7:58 PM ET
3-Hold of 5 3
B Value F Growth D Momentum D VGM
Brokerage Reports
Pfizer Inc. [PFE]
Reports for Purchase
Showing records 521 - 540 ( 561 total )
Company: Pfizer Inc.
Industry: Large Cap Pharmaceuticals
Griffin Securities Updates Coverage on Lpath, Inc. (LPTN)
Provider: GRIFFIN SECURITIES, INC.
Analyst: MARKEY K
Company: Pfizer Inc.
Industry: Large Cap Pharmaceuticals
Company: Pfizer Inc.
Industry: Large Cap Pharmaceuticals
Overall near term outlook remains quite encouraging despite slight downward revision to anagement?s CY12 guidance & Lipitor?s patent expiry.
Provider: FIRST GLOBAL
Analyst: THOMAS K
Company: Pfizer Inc.
Industry: Large Cap Pharmaceuticals
Company: Pfizer Inc.
Industry: Large Cap Pharmaceuticals
4Q Revenue and EPS Ahead of Estimates Despite Lower Lipitor Sales and Less Currency Benefit.
Provider: J.J.B. Hilliard, W.L. Lyons
Analyst: O'NEIL S
Company: Pfizer Inc.
Industry: Large Cap Pharmaceuticals
Technical Takeaways: Bullish Sector Rotation Continues; Pharmaceutical ETF may be Topping.
Provider: AURIGA USA
Analyst: ALBANESE G
Company: Pfizer Inc.
Industry: Large Cap Pharmaceuticals
Technical Takeaways: Bullish Sector Rotation Continues; Pharmaceutical ETF may be Topping.
Provider: AURIGA USA
Analyst: ALBANESE G
Company: Pfizer Inc.
Industry: Large Cap Pharmaceuticals
Dividend Increase, Share Repurchase, Management Changes
Provider: J.J.B. Hilliard, W.L. Lyons
Analyst: O'NEIL S
Company: Pfizer Inc.
Industry: Large Cap Pharmaceuticals
Company: Pfizer Inc.
Industry: Large Cap Pharmaceuticals
Overall near term outlook still remains quite encouraging despite Lipitor?s patent expiry.
Provider: FIRST GLOBAL
Analyst: THOMAS K
Company: Pfizer Inc.
Industry: Large Cap Pharmaceuticals
Company: Pfizer Inc.
Industry: Large Cap Pharmaceuticals
Company: Pfizer Inc.
Industry: Large Cap Pharmaceuticals
3Q Revenue and EPS Ahead of Expectations. Lipitor Patent Expiration Approaching
Provider: J.J.B. Hilliard, W.L. Lyons
Analyst: O'NEIL S
Company: Pfizer Inc.
Industry: Large Cap Pharmaceuticals
Company: Pfizer Inc.
Industry: Large Cap Pharmaceuticals
Company: Pfizer Inc.
Industry: Large Cap Pharmaceuticals
Company: Pfizer Inc.
Industry: Large Cap Pharmaceuticals
Company: Pfizer Inc.
Industry: Large Cap Pharmaceuticals
MODEL STOCK PORTFOLIO -CONSERVATIVE GROWTH
Provider: J.J.B. Hilliard, W.L. Lyons